Sharemaestro Newsreel

Cancer Detection Test Receives Regulatory Marking for Use in Great Britain

Personalis Inc. has received UKCA marking for its NeXT Personal Dx test, allowing its clinical use for minimal residual disease detection in Great Britain. This regulatory approval enables pharmaceutical companies to use the platform in multi-national clinical trials, standardizing detection and potentially accelerating drug …

RadNet earnings in focus as profit return looms after Q1 miss

RadNet Inc. is expected to report second-quarter earnings, with analysts anticipating a rebound to profitability at 20 cents per share on revenues of $610 million, following a Q1 loss. Investors will closely watch for resolution of operational challenges and the performance of its digital …

RadNet, Inc. (RDNT) Stock Forecasts

Argus has raised its target price for RadNet Inc. (RDNT) to $73.00, noting the company's role as a national provider of diagnostic imaging services across two segments: Imaging Center and Digital Health. The current stock price for RDNT is $72.39. The article also lists …

Quantinno Capital Management LP Has $5.30 Million Stock Holdings in Qiagen N.V. $QGEN

Quantinno Capital Management LP significantly reduced its stake in Qiagen N.V. by 40.6% in the first quarter, now holding 132,392 shares valued at approximately $5.3 million. Despite this, Qiagen's recent quarterly earnings exceeded expectations, with EPS of $0.62 and revenue of $535 million, and …

PTA-CMS: QIAGEN N.V.: Release of a capital market information

QIAGEN N.V. has filed its Form 6-K Report of Foreign Private Issuer for the quarterly period ended June 30, 2026, with the United States Securities and Exchange Commission (SEC). The document is now accessible on QIAGEN's website. This release provides important capital market information …

QIAGEN N.V. (NYSE: QGEN) tops Q2 EPS outlook and reaffirms 2026 targets

QIAGEN N.V. exceeded its Q2 2026 EPS outlook with adjusted diluted EPS of $0.62, against an outlook of at least $0.60 CER, and reaffirmed its full-year 2026 guidance for net sales growth of about 1-2% CER and adjusted diluted EPS of at least $2.43 …

Natera, Doximity, PubMatic, Airbnb And Other Big Stocks Moving Higher On Friday

Several major stocks, including Natera, Doximity, PubMatic, and Airbnb, saw significant gains on Friday due to better-than-expected quarterly financial results and raised sales guidance. Natera jumped 20.5% after beating loss estimates and exceeding revenue expectations. Doximity climbed 39%, while Airbnb rose 15.8% after both …

Prenetics (Nasdaq: PRE) files F-1 to register 2.36M warrant shares for resale

Prenetics Global Limited (Nasdaq: PRE) has filed an F-1 registration statement to allow for the resale of up to 2.36 million Class A Ordinary Shares by existing holders of Class C "Exchange Warrants." The company will not receive proceeds from the resales but may …

Catalyst Watch: Inflation reads, AMAT earnings, Google Pixel event, and MLB on Netflix

[Lower Manhattan Cityscape] Art Wager/E+ via Getty Images Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDAY - AUGUST 10 * …

MYRIAD INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Myriad Genetics, Inc. on Behalf of Myriad Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Myriad (MYGN) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Myriad and would like to discuss your legal rights, contact Bragar Eagel …

Medpace Holdings, Inc. SEC Filing (Aug 7, 2026)

This article reports on Medpace Holdings, Inc.'s SEC Form 144 filing on August 7, 2026, detailing a proposed sale of securities. The filing indicates the sale of 795 shares of common stock acquired through stock option exercise on the same date, with an aggregate …

Should You Investigate Medpace Holdings, Inc. (NASDAQ:MEDP) At US$585?

The article discusses whether Medpace Holdings, Inc. (NASDAQ:MEDP) is a good investment at its current share price of US$585. It delves into the company's valuation, considering factors such as its price-to-earnings (P/E) ratio and future growth prospects. The analysis aims to help potential investors …

Biodesix boosts sales, trims loss as diagnostics firm pushes toward profitability

Biodesix Inc. (Nasdaq: BDSX) reported improved top and bottom lines in the second quarter, indicating progress towards profitability. The life-sciences company, which specializes in lung diagnostic tools, has shown consistent efforts to boost sales and reduce losses. This financial improvement positions Biodesix on a …

Neogenomics stock hits 52-week high at 16.46 USD

NeoGenomics Inc. (NEO) stock has reached a 52-week high of $16.46, driven by strong investor confidence and recent positive financial results. Despite being considered overvalued by InvestingPro analysis, the company's stock has delivered a 170% return over the past year, with analysts predicting profitability …

Price to earnings forward of Illumina, Inc. – DUS:ILU

This page provides financial information for Illumina, Inc. (DUS:ILU) on the TradingView platform, specifically focusing on its forward price-to-earnings ratio. It indicates that the market is currently closed with no trades recorded for the company.

Sotera Health (SHC) Is Up 5.9% After Q2 Earnings Beat And Guidance Hike What’s Changed

Sotera Health Company's Q2 2026 results, released on August 6, showed revenue rising to US$321.38 million and net income to US$53.64 million, with earnings per share from continuing operations increasing to US$0.19 from US$0.03 a year earlier. Management's decision to raise full-year guidance after …

Royal Bank of Canada Grows Stock Holdings in Veracyte, Inc. $VCYT

Royal Bank of Canada increased its stake in Veracyte, Inc. (NASDAQ:VCYT) by 66.4% in the first quarter, acquiring an additional 228,720 shares, bringing its total to 573,096 shares valued at approximately $18.46 million. This move is part of a broader trend of institutional investors …

Medpace Holdings Inc (MEDP) Stock News Today

This page provides news and analysis for Medpace Holdings Inc (MEDP). It highlights the company's stock performance, including a recent surge after strong earnings, and offers various financial and analytical tools for investors. The article mentions a significant event where Medpace's strong earnings caused …

Mistras Group, Inc. (MG) Latest Stock News & Headlines

This article provides the latest stock news and headlines for Mistras Group, Inc. (MG), including its current stock price and recent news releases. It also features a performance overview, comparing MG's trailing total returns against the S&P 500, showing significant outperformance year-to-date, and over …

NeoGenomics (NEO) Is Up 8.4% After Q2 Profit Return And Raised 2026 Outlook – Has The Bull Case Changed?

NeoGenomics (NEO) reported a return to quarterly profitability in Q2 2026 with revenue of US$201.66 million and a net income of US$2.24 million, a significant improvement from a net loss the previous year. Management also narrowed its expected full-year 2026 net loss and slightly …

ICON Public Limited Company (ICLR) Stock Price, News, Quote & History

This Yahoo Finance page provides a comprehensive overview of ICON Public Limited Company (ICLR) stock, including its current price, historical data, financial performance, and analyst insights. It details the company's business as a clinical research organization offering outsourced development and commercialization services globally. The …

bioAffinity Technologies earnings beat by $1.46, revenue fell short of estimates

bioAffinity Technologies (NASDAQ: BIAF) reported a second-quarter EPS of $-0.640, significantly beating the analyst estimate of $-2.100 by $1.46. However, the company's revenue for the quarter was $1.5M, falling short of the consensus estimate of $1.7M. The stock has experienced a significant decline over …

Insight Molecular Diagnostics Inc. (7OC0.MU) Analyst Insights, Price Targets & Recommendations

This article provides analyst insights, price targets, and recommendations for Insight Molecular Diagnostics Inc. (7OC0.MU). It lists several instances where analysts from Lake Street and Needham have maintained a "Buy" rating for the company's stock between February 2026 and April 2025. The current stock …

Royal Bank of Canada Sells 23,345 Shares of Charles River Laboratories International, Inc. $CRL

Royal Bank of Canada reduced its stake in Charles River Laboratories International (NYSE:CRL) by 18.9% in the first quarter, selling 23,345 shares but still holding 100,311 shares valued at $17.3 million. Despite a year-over-year revenue decline, Charles River Laboratories exceeded Q2 earnings and revenue …

Danaher Corp. stock underperforms Friday when compared to competitors despite daily gains

Danaher Corp. (DHR) shares increased by 2.39% on Friday, closing at $204.76. Despite this daily gain and a favorable market session where the S&P 500 and Dow Jones also rose, Danaher's stock underperformed when compared to its competitors. This marked the third consecutive day …

Mettler-Toledo director Thomas P. Salice disposes of 417 common shares for USD 600,651.00

Mettler-Toledo director Thomas P. Salice sold 417 common shares for USD 600,651.00 on August 5th. Salice also exercised stock options for the same number of shares on the same day at a lower price. After these transactions, he directly owns 292 shares.

NTRA Stock Surges After Big Earnings Beat And Guidance Hike

Natera Inc. (NTRA) saw its stock surge over 18% after reporting strong Q2 earnings, beating revenue estimates significantly, and raising its full-year 2026 guidance. The company's Q2 revenue reached $752.8M, far exceeding the $661.2M consensus, while its loss per share of $0.47 was slightly …

PensionDanmark Pensionsforsikringsaktieselskab Boosts Position in Danaher Corporation $DHR

PensionDanmark Pensionsforsikringsaktieselskab increased its stake in Danaher Corporation by 13.2% in the second quarter, bringing its total holdings to 134,442 shares valued at $25.6 million. Institutional investors collectively own 79.05% of Danaher's stock, and analysts maintain a "Moderate Buy" consensus rating with an average …

Labcorp Holdings stock hits all-time high at 317.29 USD

Labcorp Holdings Inc. stock has reached an all-time high of $317.29, significantly outperforming its year-to-date returns with a nearly 27% increase. This milestone highlights the company's strong financial health, strategic market positioning, and robust growth, further supported by recent second-quarter results that surpassed Wall …

Myriad Genetics Inc (MYD.HA) stock price, news, quote and history

Insider Selling: Mettler-Toledo International (NYSE:MTD) Director Sells 417 Shares

Mettler-Toledo International (NYSE:MTD) Director Thomas Salice sold 417 shares of the company's stock for approximately $600,651, reducing his stake by 58.82%. The company recently reported strong quarterly earnings, beating analyst estimates, with revenue up 4.5% year over year. Despite mixed analyst ratings, the consensus …

Guardant Health Inc (GH) rises 10.0% as weekly rebound meets mixed medium-term tape

The diagnostics stock’s latest weekly gain sits against a 69.3% twelve-week advance, but the four-week return remains negative.

Natera (NASDAQ: NTRA) holder Jonathan Sheena plans 18,000-share stock sale

Jonathan Sheena, a holder of Natera (NASDAQ: NTRA), has filed to sell 18,000 common shares with an aggregate value of $5,951,100.00. These shares are related to ISO stock options dated March 9, 2022, and will be sold via Charles Schwab & Co., Inc. on …

THOMAS SALICE Exercises Options, Realizes $426K

THOMAS SALICE, a Board Member at Mettler-Toledo Intl (NYSE: MTD), exercised stock options for 417 shares valued at $426,711, as revealed in an SEC filing on August 7. The article also provides a financial overview of Mettler-Toledo Intl, highlighting its revenue growth, debt-to-equity ratio, …

Fulgent Genetics, Inc. (FLGT) Stock Price, News, Quote & History

This article provides a comprehensive overview of Fulgent Genetics, Inc. (FLGT), including its stock price, historical data, company profile, and financial performance. As of August 7, the stock closed at $19.14, up 3.18%. The company specializes in clinical diagnostic and therapeutic development solutions, offering …

Labcorp Stock Jumps 14% in a Month as Growth Meets Rich Valuation

Labcorp (LH) shares have rallied 14% in the past month, driven by strong Q2 earnings, expanding margins, and growth in both Diagnostics Laboratories and Biopharma Laboratory Services. While the company's operating picture has improved significantly, its valuation now sits above its longer-term norm, suggesting …